With your support, we have been able to fund outstanding research, leading toward cures and improved quality of life for children with cancer. Browse through our nearly 1,000 funded projects below.
Use the search tool to refine your results. You can also click on a heading to sort by project title, institution name, or year the grant was awarded. Click on the project title to read more information.
ALSF Funded Research Projects
|Project Title||Institution / Principal Investigator(s)||Grant Type||Year||State|
|Uncovering the Dysregulated RNA Binding Protein Network in Childhood Acute Myeloid Leukemia||Memorial Sloan-Kettering Cancer Center / Michael Kharas, PhD||'A' Award Grants||2016||New York|
|Development of an anti-KIR3DL1 Antibody to Promote Innate Immunity Against Neuroblastoma||Memorial Sloan-Kettering Cancer Center / Katherine Hsu, MD/PhD & Nai-Kong Cheung, MD/PhD||Innovation Grants||2016||New York|
|Identification of Mechanisms of Resistance to Trametinib Monotherapy in PAX-fusion Negative Rhabdomyosarcoma||National Cancer Institute / Marielle Yohe, MD/PhD||Young Investigator Grants||2016||Maryland|
|Neurocognitive Outcomes in Survivors of Childhood Leukemia with Down Syndrome||St. Jude Children's Research Hospital / Lisa Jacola, PhD||Psychosocial Grants||2016||Tennessee|
|CD47-blocking Oncolytic Vaccinia Viruses as Biotherapeutics for Pediatric Solid Tumors||St. Jude Children's Research Hospital / Stephen Gottschalk, MD & Nino Rainusso, MD||Innovation Grants||2016||Tennessee|
|Variation in Care and Outcomes in Pediatric Acute Leukemia||Children's Hospital of Philadelphia / Amanda DiNofia, MD||Young Investigator Grants||2016||Pennsylvania|
|GPC2 as an Oncogene and Immunotherapeutic Target in High-risk Neuroblastoma||Children's Hospital of Philadelphia / Kristopher Bosse, MD||Young Investigator Grants||2016||Pennsylvania|
|CD19 Delta Ex2 Isoform as a Target for Alternative Therapies in Relapsed Pediatric B-ALL||Children's Hospital of Philadelphia / Asen Bagashev, PhD||Young Investigator Grants||2016||Pennsylvania|
|Astatine-211 Meta-Astatobenzylguanidine ([211At]MABG) Targeted Radiotherapy for Disseminated Neuroblastoma||Children's Hospital of Philadelphia / John Maris, MD||Reach Grants||2016||Pennsylvania|
|DFMO Synergy with Chemo-immunotherapy to Eradicate MYC-Driven Neuroblastoma||Children's Hospital of Philadelphia / Michael Hogarty, MD||Reach Grants||2016||Pennsylvania|